Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

← Back to all medicines

Iglu Sugar Free Pastilles

⚠ This medicine appears to have been discontinued

The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.

If you were prescribed this medicine, other products containing Benzalkonium chloride solution, Compound benzoin tincture may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.

Active substance: Benzalkonium chloride solution, Compound benzoin tincture

Equivalent medicines (same active substance, strength and form)

Source: electronic medicines compendium (emc)
Official leaflet: Read the PIL on emc

What it is and what it is used for

for 2. What you need to know before you take Iglu Sugar Free Pastilles

What you need to know before you take it

E IGLU SUGAR FREE PASTILLES Do not take Iglu Sugar Free Pastilles if you are allergic (hypersensitive) to benzalkonium chloride solution, compound benzoin tincture or any of the other ingredients in this medicine (listed in Section 6). Do not give to children under 3 years. Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

continued…

How to take it

Iglu Sugar Free Pastilles 4. Possible side effects 5. How to store Iglu Sugar Free Pastilles

Possible side effects

not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

8 mm

How to store it

IGLU SUGAR FREE PASTILLES

  • Keep out of the sight and reach of children.
  • Do not use this medicine after the expiry date which is stated on the carton. The expiry date refers to the last day of that month.
  • Do not store above 25 ̊C. Store in the original package in order to protect from moisture.
  • Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer use. These measures will help to protect the environment. 6. CONTENTS OF THE PACK AND OTHER INFORMATION What Iglu Sugar Free Pastilles contain: Each pastille contains the active ingredients benzalkonium chloride solution 1.11 mg and compound benzoin tincture 8.06 mg. The other ingredients are sorbitol liquid (non crystallising), acacia, peppermint oil, simethicone antifoam, vegetable oil, carnauba wax, water. What Iglu Sugar Free Pastilles look like and contents of the pack
  • They are round light brown, flat pastilles.
  • They are available in blister strips of 12.
  • Each pack contains 24 pastilles (2 blister strips x 12). The Marketing Authorisation Holder and Manufacturer is: Ernest Jackson & Co Ltd, Crediton, Devon, EX17 3AP, UK, for Diomed Developments Ltd, Hitchin, Herts, SG4 7QR, UK. This leaflet was last revised in November 2025. PL 00094/5016R

Other formats – To request a copy of this leaflet in Braille, large print or audio please call 01363 636000.

LE66/5

8 mm

If you take more Iglu Sugar Free Pastilles than you should overdosage of the active ingredient is unlikely to occur because of the low concentrations used and the small pack size. If the dosage is grossly exceeded, sickness/nausea and vomiting may occur. If this happens you should seek medical advice. If you forget to take Iglu Sugar Free Pastilles do not worry, just carry on using them when you remember. If you have any further questions on the use of this medicine, ask your doctor, dentist or pharmacist. 4. POSSIBLE SIDE EFFECTS Like all medicines, Iglu Sugar Free Pastilles can cause side effects, although not everyone gets them. On rare occasions, hypersensitivity reactions to benzalkonium chloride occur involving difficulty in breathing, swelling of the face, neck, tongue or throat and a rash (severe allergic reactions). Stop taking this medicine and seek urgent medical attention if you experience these symptoms. Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any

Contents of the pack and other information

1. WHAT IGLU SUGAR FREE PASTILLES ARE AND WHAT THEY ARE USED FOR

  • Iglu Sugar Free Pastilles contain the active ingredients benzalkonium chloride solution and compound benzoin tincture which have antiseptic properties.
  • These pastilles ease discomfort and bring soothing relief to mouth ulcers and sore gums.
  • Iglu Sugar Free Pastilles are suitable for use by adults, the elderly and children of 3 years and above.

Frequently asked questions about Iglu Sugar Free Pastilles

What is the active substance in Iglu Sugar Free Pastilles?

The active substance in Iglu Sugar Free Pastilles is benzalkonium chloride solution, compound benzoin tincture.

Are there equivalent medicines to Iglu Sugar Free Pastilles?

Medicines with the same active substance, strength and form include: Boots Mouth Ulcer Pastilles. They are interchangeable only if your prescriber or pharmacist says so.

Where does this information come from?

This leaflet reproduces the patient information leaflet approved for Iglu Sugar Free Pastilles, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.

Can I get Iglu Sugar Free Pastilles without a prescription?

Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.

About this leaflet

The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.

  • Source: electronic medicines compendium (emc), Datapharm
  • Active substance: benzalkonium chloride solution, compound benzoin tincture
  • Official document: view the original leaflet on emc →
Medical disclaimer: This page is for information only and does not replace advice from your doctor or pharmacist. Always read the leaflet supplied with your medicine. If you are unwell, call NHS 111; in an emergency, call 999.

Medicines with the same active substance: Benzalkonium chloride solution, compound benzoin tincture (1 medicine)
See every medicine containing this substance, or browse the full A–Z of active substances.
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
Technical information intended for healthcare professionals (doctors and pharmacists). The Summary of Product Characteristics (SmPC) is the official document approved by the MHRA/EMA. It does not replace the patient leaflet or a doctor’s advice.

4.1. Therapeutic indications

For the relief of mouth ulcers and sore gums

4.2. Posology and method of administration

Adults, the elderly and children of 3 years and above: Dissolve one pastille in the mouth at 2 hourly intervals.

Do not take more than 8 pastilles per day.

4.3. Contraindications

Hypersensitivity to benzalkonium chloride, benzoin or any of the other ingredients.

Contains sorbitol. Patients with rare hereditary problems of fructose intolerance should not take this medicine.

4.5. Interaction with other medicinal products and other forms of interaction

None known

4.6. Fertility, pregnancy and lactation

Pregnancy

There is no or inadequate evidence of the safety of the active ingredients in this medicine in human pregnancy. The potential risk for humans is unknown.

In the absence of sufficient data, the use during pregnancy is not recommended.

Lactation

It is not known whether the active ingredients of this product are excreted in human breast milk.

In the absence of sufficient data, the use during lactation is not recommended.

Fertility

Studies of the effects on fertility have not been investigated

4.7. Effects on ability to drive and use machines

None known

4.8. Undesirable effects

Sensitivity to benzalkonium chloride may occur in some people.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.

4.9. Overdose

Symptoms of overdose are unlikely unless the recommended dosage is grossly exceeded, when nausea and vomiting may be seen. Treat by discontinuation, giving milk and egg whites and observation.

💬 Ask about this leaflet

Ask anything about Iglu Sugar Free Pastilles. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.

Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.

Pharmacies in major towns and cities — see the list
Pharmacies by county and region — see the full list

Browse all 2,009 towns and cities →